Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAXTM System in asymptomatic individuals

Elsevier

Available online 17 November 2022, 115861

Diagnostic Microbiology and Infectious DiseaseABSTRACT

Transmission by asymptomatic individuals is a persistent hurdle in the effort to control the spread of SARS-CoV-2. Therefore, it is essential to continue developing assays and evaluate their performance for detection of SARS-CoV-2 in individuals without COVID-19 symptoms. In this study, 223 nasopharyngeal swab specimens collected from COVID-19 asymptomatic individuals were tested using the BD SARS-CoV-2 (RT-PCR-based) reagents for the BD MAX™ System and compared with results obtained with the Biomerieux BioFire® Respiratory RT-PCR Panel. Positive and negative percent agreements of 100% (95% CI, 84.5% – 100%) and 99.0% (95% CI, 96.5% – 99.7%), respectively, were observed for the BD SARS-CoV-2 assay. These results demonstrate the effectiveness of the BD SARS-CoV-2 assay for detecting SARS-CoV-2 in asymptomatic individuals and suggest that this assay can facilitate optimized case surveillance and infection control efforts. Investigations using larger sample sizes of asymptomatic individuals would be beneficial to support the findings in this study.

Keywords

COVID-19, SARS-CoV-2

Asymptomatic, Reagents, BD MAX

© 2022 The Author(s). Published by Elsevier Inc.

留言 (0)

沒有登入
gif